mTOR: a new target in Erdheim-Chester disease?
PITIÉ-SALPÊTRIÈRE HOSPITAL; UNIVERSITÉ PIERRE ET MARIE CURIE.
Julien
J
Haroche
PITIÉ-SALPÊTRIÈRE HOSPITAL; UNIVERSITÉ PIERRE ET MARIE CURIE.
Zahir
Z
Amoura
D031249:Erdheim-Chester Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use*; D020123:Sirolimus / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D011241:Prednisone; D020123:Sirolimus